AptarGroup
Market Cap
US$7.3b
Last Updated
2020/07/13 23:53 UTC
Data Sources
Company Financials +
Executive Summary
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets.
Rewards
Risk Analysis
Snowflake Analysis
Solid track record with adequate balance sheet and pays a dividend.
Similar Companies
Share Price & News
How has AptarGroup's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ATR has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-1.6%
ATR
-2.3%
US Packaging
-0.7%
US Market
1 Year Return
-7.7%
ATR
-6.0%
US Packaging
5.3%
US Market
Return vs Industry: ATR matched the US Packaging industry which returned -6.9% over the past year.
Return vs Market: ATR underperformed the US Market which returned 6.7% over the past year.
Shareholder returns
| ATR | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.6% | -2.3% | -0.7% |
| 30 Day | 7.7% | 1.8% | 4.6% |
| 90 Day | 9.0% | 4.5% | 14.0% |
| 1 Year | -6.6%-7.7% | -3.8%-6.0% | 7.6%5.3% |
| 3 Year | 31.5%26.3% | -1.4%-8.2% | 34.9%26.1% |
| 5 Year | 90.8%77.3% | 31.0%14.1% | 62.3%44.7% |
Price Volatility Vs. Market
How volatile is AptarGroup's share price compared to the market and industry in the last 5 years?
Simply Wall St News
13 hours ago | Simply Wall St
Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching1 week ago | Simply Wall St
Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)3 weeks ago | Simply Wall St
Here's Why AptarGroup (NYSE:ATR) Can Manage Its Debt ResponsiblyValuation
Is AptarGroup undervalued compared to its fair value and its price relative to the market?
30.88x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ATR ($113.43) is trading above our estimate of fair value ($110.55)
Significantly Below Fair Value: ATR is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ATR is poor value based on its PE Ratio (30.9x) compared to the US Packaging industry average (16.6x).
PE vs Market: ATR is poor value based on its PE Ratio (30.9x) compared to the US market (16.2x).
Price to Earnings Growth Ratio
PEG Ratio: ATR is poor value based on its PEG Ratio (2.5x)
Price to Book Ratio
PB vs Industry: ATR is overvalued based on its PB Ratio (4.6x) compared to the US Packaging industry average (2.9x).
Next Steps
Future Growth
How is AptarGroup forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
12.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ATR's forecast earnings growth (12.3% per year) is above the savings rate (2.2%).
Earnings vs Market: ATR's earnings (12.3% per year) are forecast to grow slower than the US market (22.9% per year).
High Growth Earnings: ATR's earnings are forecast to grow, but not significantly.
Revenue vs Market: ATR's revenue (5.1% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: ATR's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ATR's Return on Equity is forecast to be low in 3 years time (15.4%).
Next Steps
Past Performance
How has AptarGroup performed over the past 5 years?
3.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ATR has high quality earnings.
Growing Profit Margin: ATR's current net profit margins (8.3%) are higher than last year (7.1%).
Past Earnings Growth Analysis
Earnings Trend: ATR's earnings have grown by 3.4% per year over the past 5 years.
Accelerating Growth: ATR's earnings growth over the past year (18%) exceeds its 5-year average (3.4% per year).
Earnings vs Industry: ATR earnings growth over the past year (18%) exceeded the Packaging industry 1.4%.
Return on Equity
High ROE: ATR's Return on Equity (14.8%) is considered low.
Next Steps
Financial Health
How is AptarGroup's financial position?
Financial Position Analysis
Short Term Liabilities: ATR's short term assets ($1.5B) exceed its short term liabilities ($891.3M).
Long Term Liabilities: ATR's short term assets ($1.5B) exceed its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: ATR's debt to equity ratio (84%) is considered high.
Reducing Debt: ATR's debt to equity ratio has increased from 81.1% to 84% over the past 5 years.
Debt Coverage: ATR's debt is well covered by operating cash flow (39.2%).
Interest Coverage: ATR's interest payments on its debt are well covered by EBIT (12x coverage).
Balance Sheet
Next Steps
Dividend
What is AptarGroup current dividend yield, its reliability and sustainability?
1.27%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ATR's dividend (1.27%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.68%).
High Dividend: ATR's dividend (1.27%) is low compared to the top 25% of dividend payers in the US market (4.6%).
Stability and Growth of Payments
Stable Dividend: ATR's dividends per share have been stable in the past 10 years.
Growing Dividend: ATR's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (39.2%), ATR's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ATR's dividends in 3 years are forecast to be well covered by earnings (37.4% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.8yrs
Average management tenure
CEO
Stephan Tanda (55yo)
3.42yrs
Tenure
US$7,918,040
Compensation
Mr. Stephan B. Tanda, MBA, serves as an Independent Director at Ingredion Incorporated since August 19, 2019. He has been Chief Executive Officer and President at AptarGroup, Inc. since February 01, 2017. ...
CEO Compensation Analysis
Compensation vs Market: Stephan's total compensation ($USD7.92M) is about average for companies of similar size in the US market ($USD7.34M).
Compensation vs Earnings: Stephan's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.42yrs | US$7.92m | 0.067% $4.9m | |
| Executive VP | 11.83yrs | US$3.67m | 0.11% $8.1m | |
| Executive Vice President of Strategic Projects & Commercial Excellence | 0.58yr | US$2.19m | 0.072% $5.3m | |
| President of Aptar Pharma | 4.5yrs | US$3.31m | 0.049% $3.6m | |
| President of Aptar Asia | 1.75yrs | US$1.57m | 0.035% $2.6m | |
| Senior VP of Investor Relations & Communications | no data | no data | no data | |
| Chief Human Resources Officer | 1.67yrs | no data | 0.017% $1.2m | |
| President of Aptar Beauty + Home | 1.83yrs | no data | 0.018% $1.3m | |
| President of Aptar Food + Beverage | 0.58yr | no data | 0.015% $1.1m |
1.8yrs
Average Tenure
54yo
Average Age
Experienced Management: ATR's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.42yrs | US$7.92m | 0.067% $4.9m | |
| Independent Chairman | 2.17yrs | US$350.00k | 0.023% $1.7m | |
| Independent Director | 21.5yrs | US$257.00k | 0.024% $1.8m | |
| Independent Director | 2.42yrs | US$255.00k | 0.0063% $456.5k | |
| Independent Director | 11.17yrs | US$247.00k | 0.018% $1.3m | |
| Independent Director | 10.17yrs | US$262.00k | 0.016% $1.2m | |
| Independent Director | 1.17yrs | US$247.00k | 0.0041% $296.3k | |
| Independent Director | 6.33yrs | US$253.00k | 0.015% $1.1m | |
| Independent Director | 2.42yrs | US$247.00k | 0.0063% $456.5k | |
| Independent Director | 5.5yrs | US$268.00k | 0.0067% $491.4k |
4.5yrs
Average Tenure
64yo
Average Age
Experienced Board: ATR's board of directors are considered experienced (4.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ATR insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
AptarGroup, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: AptarGroup, Inc.
- Ticker: ATR
- Exchange: NYSE
- Founded: 1992
- Industry: Metal and Glass Containers
- Sector: Materials
- Market Cap: US$7.281b
- Shares outstanding: 64.19m
- Website: https://www.aptar.com
Number of Employees
Location
- AptarGroup, Inc.
- 265 Exchange Drive
- Suite 100
- Crystal Lake
- Illinois
- 60014
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ATR | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Apr 1993 |
| AGT | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Apr 1993 |
Biography
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; and elastomer for injectable primary packaging components. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/07/13 23:53 |
| End of Day Share Price | 2020/07/13 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.